Cancer Therapeutics and Supportive Care Drugs Market


Posted December 15, 2017 by Infinium63

The report on Cancer Therapeutics and Supportive Care Drugs Market by Infinium Global Research analyzes over the period of 2017 to 2023.

 
The report on Cancer Therapeutics and Supportive Care Drugs Market by Infinium Global Research analyzes over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Cancer Therapeutics and Supportive Care Drugs Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Cancer Therapeutics and Supportive Care Drugs Market.

The global market for cancer therapeutics and supportive care drugs was valued at around USD 117.8 billion in 2016 and is expected to reach USD 222.9 billion by 2023, growing at a CAGR of around 9.7% during the forecast period of 2017 to 2023. Cancer, also called malignancy, is an abnormal growth of cells. There are more than 100 types of cancer, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Symptoms vary depending on the type. Cancer treatment may include chemotherapy, radiation, and/or surgery. 2015 year saw a new high in the number of US Food and Drug Administration approvals of new pharmaceuticals, including new molecular entities (NMEs) and new Biologic License Applications (BLAs), amounting to a total of 45 NMEs and BLAs in all disease states compared with 41 approved in 2014 and much fewer (27) in 2013. Of these 45 NMEs and BLAs entering the market last year, 16 were novel therapies for cancer, providing patients new hope through novel treatment options and new mechanisms of action. New trends in oncology drug development are reflected in the increasing use of biotechnology in the development of anticancer drugs, including immunotherapies or monoclonal antibodies, adoptive-cell therapies, and new vaccines.

Get a Sample Report @ https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/22

Companies profiled:
Abbott Laboratories,
AstraZeneca plc,
Astellas Pharma Inc.,
Bristol-Myers Squibb,
Johnson & Johnson,
Eli Lilly,
Novartis,
Pfizer Inc.,
Sanofi, AbbVie, Inc.,
Teva Pharmaceuticals,
Takeda Pharmaceuticals, etc.

Make an Enquiry @ https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/22

Key topics covered:

1.Scope of the report
2 Executive summary
3 Oncology overview
4 Qualitative analysis
5 Global cancer therapeutics and supportive care drugs market, by type, 2017 – 2023
6 Global cancer therapeutics and supportive care drugs market, by distribution channel, 2017 – 2023
7 Global cancer therapeutics and supportive care drugs market, by geography, 2017 – 2023
8 Company profiles

Click to View Complete Report @ https://www.infiniumglobalresearch.com/healthcare_medical_devices/cancer_therapeutics_supportive_care_drugs_market
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Infinium Global Research
Country India
Categories Health
Tags cancer therapeutics and supportive care drugs , cancer therapeutics and supportive care drugs market , cancer therapeutics and supportive care drugs market analysis , cancer therapeutics and supportive care drugs market forecast , cancer therapeutics and supportive care drugs market share , cancer therapeutics and supportive care drugs market size , research report cancer therapeutics and supportive care drugs market
Last Updated December 15, 2017